Biochemical characterization and evaluation of potent inhibitors of the Pseudomonas aeruginosa PA01 acetohydroxyacid synthase

详细信息    查看全文

• 作者：June-Haeng Cho¹ ; Mi-Young Lee¹ ; Irshad Ahmed Baig ; Na-Reum Ha ; Joungmok Kim² ; Moon-Young Yoon ; ^{myyoon@hanyang.ac.kr}
• 关键词：AHAS ; Inhibitors ; Pseudomonas aeruginosa ; MIC ; BCAAs
• 刊名：Biochimie
• 出版年：2013
• 出版时间：July, 2013
• 年：2013
• 卷：95
• 期：7
• 页码：1411-1421
• 全文大小：3386 K

文摘

Microbes and plants synthesize essential branched-chain amino acids (BCAAs) such as valine, leucine, and isoleucine via a common biosynthetic pathway in which the first reaction is catalyzed by acetohydroxyacid synthase (AHAS, EC 4.1.3.18). Recently, AHAS was identified as a potential anti bacterial target. To help find an effective inhibitor that could act as an antibacterial compound, we cloned and characterized the catalytic subunit (CSU) of Pseudomonas aeruginosa AHAS, and found four potent inhibitors through chemical library screening. The ilvI gene of P.?aeruginosa encodes a 65-kDa AHAS protein, consistent with the size of the purified enzyme on SDS-PAGE. Enzyme kinetics showed that the enzyme has a K_m of 14.2?mM and a specific activity of 0.12?U/mg. Enzyme activity was optimum at a temperature of 37?¡ãC and a pH of 7.5. The K_d for thiamine diphosphate (ThDP) was 89.92?¡À?17.9?¦ÌM, as determined by fluorescence quenching. The cofactor activation constants (K_s) for ThDP and (K_c) for Mg²⁺ were 0.6?¡À?0.1 and 560.8?¡À?7.4?¦ÌM, respectively. Further, we determined that AVS2087, AVS2093, AVS2236, and AVS2387 compounds are potent inhibitors of the catalytic subunit of P.?aeruginosa AHAS. These compounds inhibit nearly 100 % of AHAS activity, with IC₅₀ values of 1.19?¦ÌM, 5.0?nM, 25?nM, and 13?nM, respectively. Compound AVS2093 showed growth inhibition with a minimal inhibitory concentration (MIC) of 742.9?¦Ìg/ml against P.?aeruginosa strain ATCC 9027. Furthermore, these findings were supported by molecular docking studies with the AVS compounds against P.?aeruginosa AHAS in which AVS2093 showed minimum binding energy (?7.8?kJ/mol) by interacting with the receptor through a single hydrogen bond of 2.873??. Correlation of AVS2093 activity with P.?aeruginosa AHAS cell growth inhibition suggested that AHAS might serve as a target protein for the development of novel antibacterial therapeutics. Results of the current study provide an impetus to further evaluate the potency of these inhibitors against pathogenic P. aeruginosa strains in?vivo and to design more potent antibacterial agents based on these AVS inhibitors.